MX341588B - Procedimiento de sintesis enzimatica de la (7s)-1-(3,4-dimetoxibic iclo [4.2.0] octa-1,3,5-trien-7-il) n-metil metanamina, y aplicacion a la sintesis de la ivabradina y de sus sales. - Google Patents

Procedimiento de sintesis enzimatica de la (7s)-1-(3,4-dimetoxibic iclo [4.2.0] octa-1,3,5-trien-7-il) n-metil metanamina, y aplicacion a la sintesis de la ivabradina y de sus sales.

Info

Publication number
MX341588B
MX341588B MX2013008022A MX2013008022A MX341588B MX 341588 B MX341588 B MX 341588B MX 2013008022 A MX2013008022 A MX 2013008022A MX 2013008022 A MX2013008022 A MX 2013008022A MX 341588 B MX341588 B MX 341588B
Authority
MX
Mexico
Prior art keywords
synthesis
ivabradine
octa
salts
dimethoxybicyc
Prior art date
Application number
MX2013008022A
Other languages
English (en)
Other versions
MX2013008022A (es
Inventor
Pedragosa Moreau Sandrine
Lefoulon François
Morís Varas Francisco
González Sabín Javier
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MX2013008022A publication Critical patent/MX2013008022A/es
Publication of MX341588B publication Critical patent/MX341588B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • C12P41/008—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving carbamates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01003—Triacylglycerol lipase (3.1.1.3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invención se refiere a procedimiento de síntesis enzimática del compuesto de fórmula (I), la (7S)-1-(3,4-dimetoxibi ciclo [4.2.0] octa-1,3,5-trien-7-il) N-metil metanamina: (ver Fórmula) Aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable.
MX2013008022A 2012-07-17 2013-07-10 Procedimiento de sintesis enzimatica de la (7s)-1-(3,4-dimetoxibic iclo [4.2.0] octa-1,3,5-trien-7-il) n-metil metanamina, y aplicacion a la sintesis de la ivabradina y de sus sales. MX341588B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1256913A FR2993561B1 (fr) 2012-07-17 2012-07-17 Procede de synthese enzymatique de la (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, et application a la synthese de l'ivabradine et de ses sels

Publications (2)

Publication Number Publication Date
MX2013008022A MX2013008022A (es) 2014-01-21
MX341588B true MX341588B (es) 2016-08-26

Family

ID=46826832

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008022A MX341588B (es) 2012-07-17 2013-07-10 Procedimiento de sintesis enzimatica de la (7s)-1-(3,4-dimetoxibic iclo [4.2.0] octa-1,3,5-trien-7-il) n-metil metanamina, y aplicacion a la sintesis de la ivabradina y de sus sales.

Country Status (33)

Country Link
US (1) US9045788B2 (es)
EP (1) EP2687506B1 (es)
JP (1) JP5822880B2 (es)
KR (1) KR101495614B1 (es)
CN (1) CN103540625B (es)
AR (1) AR091765A1 (es)
AU (1) AU2013206562B2 (es)
BR (1) BR102013017550A2 (es)
CA (1) CA2820192C (es)
CY (1) CY1116500T1 (es)
DK (1) DK2687506T3 (es)
EA (1) EA024637B1 (es)
ES (1) ES2547897T3 (es)
FR (1) FR2993561B1 (es)
GE (1) GEP20156422B (es)
HR (1) HRP20150906T1 (es)
HU (1) HUE025113T2 (es)
JO (1) JO3159B1 (es)
MA (1) MA34880B1 (es)
MD (1) MD4375C1 (es)
MX (1) MX341588B (es)
MY (1) MY177115A (es)
NZ (1) NZ612592A (es)
PL (1) PL2687506T3 (es)
PT (1) PT2687506E (es)
RS (1) RS54082B1 (es)
SA (1) SA113340722B1 (es)
SG (1) SG196717A1 (es)
SI (1) SI2687506T1 (es)
TW (1) TWI485250B (es)
UA (1) UA113052C2 (es)
UY (1) UY34900A (es)
WO (1) WO2014013179A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6616934B2 (ja) * 2014-05-22 2019-12-04 株式会社 資生堂 レナリドミドの光学分割方法
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN110656134B (zh) * 2018-06-29 2023-03-28 广东东阳光药业有限公司 一种单酯的制备方法
CN110483312A (zh) * 2019-08-27 2019-11-22 北京阳光诺和药物研究有限公司 一种高纯度盐酸伊伐布雷定及其中间体的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
US5981267A (en) * 1996-01-24 1999-11-09 The Scripps Research Institute Enantioselection of amines using homocarbonates with hydrolase
RU2308451C2 (ru) * 2001-09-12 2007-10-20 Анормед, Инк. Способы получения рацемического аминозамещенного 5,6,7,8-тетрагидрохинолина или рацемического аминозамещенного 5,6,7,8-тетрагидроизохинолина, способы их разделения и рацемизации, способ получения кетозамещенного 5,6,7,8-тетрагидрохинолина или кетозамещенного 5,6,7,8-тетрагидроизохинолина, способ получения энантиомера конденсированного бициклического кольца, замещенного первичным амином, производные 5,6,7,8-тетрагидрохинолина
KR100510379B1 (ko) * 2003-07-31 2005-08-25 동부아남반도체 주식회사 트렌치 소자 분리 형성 방법
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868775B1 (fr) * 2004-04-13 2008-04-11 Servier Lab Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2935381B1 (fr) * 2008-08-29 2010-12-17 Servier Lab Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine
CN102264689B (zh) * 2008-12-22 2014-12-31 新梅斯托克尔卡公司 制备伊伐布雷定的方法
HUP1000245A2 (en) * 2010-05-07 2011-11-28 Richter Gedeon Nyrt Industrial process for the production ivabradin salts
EP2495237A1 (en) * 2011-03-04 2012-09-05 Alembic Pharmaceuticals Limited An improved process for the preparation of highly pure ivabradine hydrochloride

Also Published As

Publication number Publication date
ES2547897T3 (es) 2015-10-09
EA024637B1 (ru) 2016-10-31
MD4375B1 (ro) 2015-10-31
GEP20156422B (en) 2016-01-11
JP5822880B2 (ja) 2015-11-25
WO2014013179A1 (fr) 2014-01-23
PT2687506E (pt) 2015-08-11
MX2013008022A (es) 2014-01-21
FR2993561A1 (fr) 2014-01-24
MA34880B1 (fr) 2014-02-01
EP2687506A1 (fr) 2014-01-22
JO3159B1 (ar) 2017-09-20
HUE025113T2 (en) 2016-02-29
EA201300719A3 (ru) 2014-04-30
EP2687506B1 (fr) 2015-06-24
FR2993561B1 (fr) 2014-10-31
CY1116500T1 (el) 2017-03-15
MD4375C1 (ro) 2016-05-31
HRP20150906T1 (hr) 2015-09-25
SA113340722B1 (ar) 2015-07-23
TW201406960A (zh) 2014-02-16
UY34900A (es) 2014-02-28
DK2687506T3 (en) 2015-09-28
NZ612592A (en) 2014-05-30
MY177115A (en) 2020-09-07
CN103540625A (zh) 2014-01-29
CN103540625B (zh) 2016-08-17
US9045788B2 (en) 2015-06-02
UA113052C2 (xx) 2016-12-12
SI2687506T1 (sl) 2015-11-30
AU2013206562B2 (en) 2017-02-02
TWI485250B (zh) 2015-05-21
RS54082B1 (en) 2015-10-30
CA2820192A1 (fr) 2014-01-17
MD20130045A2 (en) 2014-01-31
AR091765A1 (es) 2015-02-25
KR101495614B1 (ko) 2015-02-25
EA201300719A2 (ru) 2014-02-28
CA2820192C (fr) 2016-03-22
JP2014018204A (ja) 2014-02-03
PL2687506T3 (pl) 2015-10-30
BR102013017550A2 (pt) 2015-06-30
SG196717A1 (en) 2014-02-13
US20140024088A1 (en) 2014-01-23
KR20140010900A (ko) 2014-01-27
AU2013206562A1 (en) 2014-02-06

Similar Documents

Publication Publication Date Title
GEP20125491B (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
GEP20125407B (en) New process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
UA105890C2 (uk) Спосіб розділення енантіомерів (3,4-диметоксибіцикло[4.2.0]окта-1,3,5-триєн-7-іл)нітрилу і застосування в синтезі івабрадину
MX2011007978A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MX341588B (es) Procedimiento de sintesis enzimatica de la (7s)-1-(3,4-dimetoxibic iclo [4.2.0] octa-1,3,5-trien-7-il) n-metil metanamina, y aplicacion a la sintesis de la ivabradina y de sus sales.
MX2010003213A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MX2012002818A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MX2010003184A (es) Nuevo procedimiento de sinstesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
UA106208C2 (ru) Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
WO2013117869A3 (fr) Procédé de synthèse enzymatique de l'acide (7s)-3,4-dimethoxybicyclo [4.2.0]|octa-1,3,5-triene-7-carboxylique ou de ses esters, et application a la synthèse|de l'ivabradine et de ses sels
MD20140048A2 (en) Process for the synthesis of 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MD4477B1 (ro) Procedeu de sinteză a 3-(2-bromo-4,5-dimetoxifenil)propannitrilului şi aplicarea acestuia în sinteza ivabradinei şi a sărurilor sale de adiţie cu un acid farmaceutic acceptabil
MX347536B (es) Procedimiento de sintesis enzimatica del acido (7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-carboxilico y aplicacion en la sintesis de ivabradina y de sus sales.
MX346640B (es) Procedimiento de sintesis de derivados de la 7,8-dimetoxi-1,3-dihi dro-2h-3-benzazepin-2-ona y aplicación a la sintesis de la ivabradina.
SG165255A1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid

Legal Events

Date Code Title Description
FG Grant or registration